β-carotene in HIV infection

Gregg O. Coodley, Heidi Nelson, Mark O. Loveless, Cathi Folk

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

β-Carotene has been reported to have an immunostimulatory effect. Recent studies suggest that β-carotene supplementation can increase CD4 counts in HIV-infected patients. Our double-blind, placebo-controlled clinical trial was designed to test the efficacy of β-carotene in raising CD4 counts in HIV-infected patients. Twenty-one HIV-seropositive patients were randomized to receive either β-carotene. 180 mg/day or placebo for 4 weeks, and then crossed over to receive the alternative treatment for the following 4 weeks. β-Carotene resulted in a statistically significant increase in total WBC count (p = 0.01), % change in CD4 count (p = 0.02), and % change in CD4/CD8 ratios (p = 0.02) compared to placebo. The absolute CD4 count, absolute CD4/CD8 ratio, and total and B-lymphocytes all increased on carotene and fell during placebo, but these differences did not reach statistical significance. No toxicity was observed on either treatment. β-Carotene appears to have an immunostimulatory effect in HIV-infected patients. Further studies are needed to demonstrate whether β-carotene has a role as adjunct therapy in treatment of HIV-infected patients.

Original languageEnglish (US)
Pages (from-to)270-271
Number of pages2
JournalJournal of Acquired Immune Deficiency Syndromes
Volume6
Issue number3
StatePublished - 1993

Fingerprint

Carotenoids
HIV Infections
CD4 Lymphocyte Count
HIV
Placebos
CD4-CD8 Ratio
Controlled Clinical Trials
Therapeutics
B-Lymphocytes

Keywords

  • HIV
  • Immunostimulation
  • T-helper cell
  • Vitamin A
  • β-Carotene

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Coodley, G. O., Nelson, H., Loveless, M. O., & Folk, C. (1993). β-carotene in HIV infection. Journal of Acquired Immune Deficiency Syndromes, 6(3), 270-271.

β-carotene in HIV infection. / Coodley, Gregg O.; Nelson, Heidi; Loveless, Mark O.; Folk, Cathi.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 6, No. 3, 1993, p. 270-271.

Research output: Contribution to journalArticle

Coodley, GO, Nelson, H, Loveless, MO & Folk, C 1993, 'β-carotene in HIV infection', Journal of Acquired Immune Deficiency Syndromes, vol. 6, no. 3, pp. 270-271.
Coodley, Gregg O. ; Nelson, Heidi ; Loveless, Mark O. ; Folk, Cathi. / β-carotene in HIV infection. In: Journal of Acquired Immune Deficiency Syndromes. 1993 ; Vol. 6, No. 3. pp. 270-271.
@article{2dba7bda1c284639ab6861470685e98c,
title = "β-carotene in HIV infection",
abstract = "β-Carotene has been reported to have an immunostimulatory effect. Recent studies suggest that β-carotene supplementation can increase CD4 counts in HIV-infected patients. Our double-blind, placebo-controlled clinical trial was designed to test the efficacy of β-carotene in raising CD4 counts in HIV-infected patients. Twenty-one HIV-seropositive patients were randomized to receive either β-carotene. 180 mg/day or placebo for 4 weeks, and then crossed over to receive the alternative treatment for the following 4 weeks. β-Carotene resulted in a statistically significant increase in total WBC count (p = 0.01), {\%} change in CD4 count (p = 0.02), and {\%} change in CD4/CD8 ratios (p = 0.02) compared to placebo. The absolute CD4 count, absolute CD4/CD8 ratio, and total and B-lymphocytes all increased on carotene and fell during placebo, but these differences did not reach statistical significance. No toxicity was observed on either treatment. β-Carotene appears to have an immunostimulatory effect in HIV-infected patients. Further studies are needed to demonstrate whether β-carotene has a role as adjunct therapy in treatment of HIV-infected patients.",
keywords = "HIV, Immunostimulation, T-helper cell, Vitamin A, β-Carotene",
author = "Coodley, {Gregg O.} and Heidi Nelson and Loveless, {Mark O.} and Cathi Folk",
year = "1993",
language = "English (US)",
volume = "6",
pages = "270--271",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - β-carotene in HIV infection

AU - Coodley, Gregg O.

AU - Nelson, Heidi

AU - Loveless, Mark O.

AU - Folk, Cathi

PY - 1993

Y1 - 1993

N2 - β-Carotene has been reported to have an immunostimulatory effect. Recent studies suggest that β-carotene supplementation can increase CD4 counts in HIV-infected patients. Our double-blind, placebo-controlled clinical trial was designed to test the efficacy of β-carotene in raising CD4 counts in HIV-infected patients. Twenty-one HIV-seropositive patients were randomized to receive either β-carotene. 180 mg/day or placebo for 4 weeks, and then crossed over to receive the alternative treatment for the following 4 weeks. β-Carotene resulted in a statistically significant increase in total WBC count (p = 0.01), % change in CD4 count (p = 0.02), and % change in CD4/CD8 ratios (p = 0.02) compared to placebo. The absolute CD4 count, absolute CD4/CD8 ratio, and total and B-lymphocytes all increased on carotene and fell during placebo, but these differences did not reach statistical significance. No toxicity was observed on either treatment. β-Carotene appears to have an immunostimulatory effect in HIV-infected patients. Further studies are needed to demonstrate whether β-carotene has a role as adjunct therapy in treatment of HIV-infected patients.

AB - β-Carotene has been reported to have an immunostimulatory effect. Recent studies suggest that β-carotene supplementation can increase CD4 counts in HIV-infected patients. Our double-blind, placebo-controlled clinical trial was designed to test the efficacy of β-carotene in raising CD4 counts in HIV-infected patients. Twenty-one HIV-seropositive patients were randomized to receive either β-carotene. 180 mg/day or placebo for 4 weeks, and then crossed over to receive the alternative treatment for the following 4 weeks. β-Carotene resulted in a statistically significant increase in total WBC count (p = 0.01), % change in CD4 count (p = 0.02), and % change in CD4/CD8 ratios (p = 0.02) compared to placebo. The absolute CD4 count, absolute CD4/CD8 ratio, and total and B-lymphocytes all increased on carotene and fell during placebo, but these differences did not reach statistical significance. No toxicity was observed on either treatment. β-Carotene appears to have an immunostimulatory effect in HIV-infected patients. Further studies are needed to demonstrate whether β-carotene has a role as adjunct therapy in treatment of HIV-infected patients.

KW - HIV

KW - Immunostimulation

KW - T-helper cell

KW - Vitamin A

KW - β-Carotene

UR - http://www.scopus.com/inward/record.url?scp=84938479543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938479543&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 270

EP - 271

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -